Norfloxacin Modulates the Inflammatory Response and Directly Affects Neutrophils in Patients With Decompensated Cirrhosis

Gastroenterology

Volumn 137, Issue 5, 2009, Pages

  Zapater, Pedro ^a,b   Caño, Rocío ^a   Llanos, Lucía ^a   Ruiz Alcaraz, Antonio J ^c   Pascual, Sonia ^a,b   Barquero, Claudia ^a   Moreu, Rocío ^a   Bellot, Pablo ^a   Horga, José F ^a   Muñoz, Carlos ^a   Pérez, Jara ^a   García Peñarrubia, Pilar ^c   Pérez Mateo, Miguel ^a   Such, José ^a,b   Francés, Rubén ^a,b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIUM LIPOPOLYSACCHARIDE; COTRIMOXAZOLE; GAMMA INTERFERON; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; NITRIC OXIDE; NORFLOXACIN; PHORBOL 13 ACETATE 12 MYRISTATE; SULFAMETHOXAZOLE; SUPEROXIDE; TRANSCRIPTION FACTOR RELA; TRIMETHOPRIM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASCITES; ASCITES FLUID; BLOOD SAMPLING; CELLULAR STRESS RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; DECOMPENSATED LIVER CIRRHOSIS; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE FLORA; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY BURST; SINGLE DRUG DOSE;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COHORT STUDIES; CROSS-OVER STUDIES; CYTOKINES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NF-KAPPA B; NORFLOXACIN; PERITONITIS; RESPIRATORY BURST;

EID: 70350100353     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.07.058     Document Type: Article

References (24)

1. Guarner C., and Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 17 (1997) 203-217
2. Such J., and Runyon B.A. Spontaneous bacterial peritonitis. Clin Infect Dis 27 (1998) 669-674
3. Soriano G., Guarner C., Tomas A., et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 103 (1992) 1267-1272
4. Gines P., Rimola A., Planas R., et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 12 (1990) 716-724
5. Rimola A., Garcia-Tsao G., Navasa M., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32 (2000) 142-153
6. Zapater P., Frances R., Gonzalez-Navajas J.M., et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 48 (2008) 1924-1931
7. Fernandez J., Navasa M., Planas R., et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133 (2007) 818-824
8. Frances R., Zapater P., Gonzalez-Navajas J.M., et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 47 (2008) 978-985
9. Dalhoff A., and Shalit I. Immunomodulatory effects of quinolones. Lancet Infect Dis 3 (2003) 359-371
10. Lorne E., Zmijewski J.W., Zhao X., et al. Role of extracellular superoxide in neutrophil activation: interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine production. Am J Physiol Cell Physiol 294 (2008) C985-C993
11. El B.R., Alvarez M., Carballo M., et al. Activation of phagocytic cell NADPH oxidase by norfloxacin: a potential mechanism to explain its bactericidal action. J Leukoc Biol 71 (2002) 255-261
12. Mitra S., and Abraham E. Participation of superoxide in neutrophil activation and cytokine production. Biochim Biophys Acta 1762 (2006) 732-741
13. Luo H.R., and Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. Am J Hematol 83 (2008) 288-295
14. Frances R., Benlloch S., Zapater P., et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 39 (2004) 484-491
15. Bedor D.C., Goncalves T.M., Ferreira M.L., et al. Simultaneous determination of sulfamethoxazole and trimethoprim in biological fluids for high-throughput analysis: comparison of HPLC with ultraviolet and tandem mass spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 863 (2008) 46-54
16. Wennmalm A., Benthin G., Edlund A., et al. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73 (1993) 1121-1127
17. Swanson B.N., Boppana V.K., Vlasses P.H., et al. Norfloxacin disposition after sequentially increasing oral doses. Antimicrob Agents Chemother 23 (1983) 284-288
18. Aparicio J.R., Such J., Pascual S., et al. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 31 (1999) 277-283
19. Novella M., Sola R., Soriano G., et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 25 (1997) 532-536
20. Navasa M., Follo A., Filella X., et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27 (1998) 1227-1232
21. Garcia-Tsao G., Angulo P., Garcia J.C., et al. The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis. Hepatology 28 (1998) 17-21
22. Aderem A. Role of Toll-like receptors in inflammatory response in macrophages. Crit Care Med 29 (2001) S16-S18
23. Such J., Guarner C., Soriano G., et al. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis. Hepatology 12 (1990) 1175-1178
24. Albillos A., de La H.A., Gonzalez M., et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37 (2003) 208-217